Cited 0 times in 
Cited 2 times in 
Comparison of Three Cardiovascular Risk Scores among HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bae, Ji Yun | - |
| dc.contributor.author | Kim, Soo Min | - |
| dc.contributor.author | Choi, Yunsu | - |
| dc.contributor.author | Choi, Jun Yong | - |
| dc.contributor.author | Klm, Sang Il | - |
| dc.contributor.author | Kim, Shin -Woo | - |
| dc.contributor.author | Park, Bo Young | - |
| dc.contributor.author | Choi, Bo Youl | - |
| dc.contributor.author | Choi, Hee Jung | - |
| dc.date.accessioned | 2023-03-10T01:29:27Z | - |
| dc.date.available | 2023-03-10T01:29:27Z | - |
| dc.date.created | 2023-03-14 | - |
| dc.date.issued | 2022-09 | - |
| dc.identifier.issn | 2093-2340 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/193188 | - |
| dc.description.abstract | Background: We investigated cardiovascular disease (CVD), risk factors for CVD, and applicability of the three known CVD risk equations in the Korean human immunodeficiency virus/ Acquired Immune Deficiency Syndrome (HIV/AIDS) cohort.Materials and Methods: The study parcitipants were HIV-infected patients in a Korean HIV/ AIDS cohort enrolled from 19 hospitals between 2006 and 2017. Data collected at entry to the cohort were analyzed. The 5-year CVD risk in each participant was calculated using three CVD risk equations: reduced CVD prediction model of HIV-specific data collection on adverse effects of anti-HIV drugs (R-DAD), Framingham general CVD risk score (FRS), and Korean Coronary Heart Disease Risk Score (KRS).Results: CVD events were observed in 11 of 586 HIV-infected patients during a 5-year (median) follow-up period. The incidence of CVD was 4.11 per 1,000 person-years. Older age (64 vs. 41 years, P = 0.005) and diabetes mellitus (45.5% vs. 6.4%, P <0.001) were more frequent in patients with CVD. Using R-DAD, FRS, and KRS, 1.9%, 2.4%, and 0.7% of patients, respectively, were considered to have a very high risk (>= 10%) of 5-year CVD. The discriminatory capacities of the three prediction models were good, with c-statistic values of 0.829 (P <0.001) for R-DAD, 0.824 (P <0.001) for FRS, and 0.850 (P = 0.001) for KRS.Conclusion: The FRS, R-DAD, and KRS performed well in the Korean HIV/AIDS cohort. A larger cohort and a longer period of follow-up may be necessary to demonstrate the risk factors and develop an independent CVD risk prediction model specific to Korean patients with HIV. | - |
| dc.description.statementOfResponsibility | open | - |
| dc.language | Korean, English | - |
| dc.publisher | 대한감염학회 | - |
| dc.relation.isPartOf | Infection and Chemotherapy | - |
| dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Comparison of Three Cardiovascular Risk Scores among HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Bae, Ji Yun | - |
| dc.contributor.googleauthor | Kim, Soo Min | - |
| dc.contributor.googleauthor | Choi, Yunsu | - |
| dc.contributor.googleauthor | Choi, Jun Yong | - |
| dc.contributor.googleauthor | Klm, Sang Il | - |
| dc.contributor.googleauthor | Kim, Shin -Woo | - |
| dc.contributor.googleauthor | Park, Bo Young | - |
| dc.contributor.googleauthor | Choi, Bo Youl | - |
| dc.contributor.googleauthor | Choi, Hee Jung | - |
| dc.identifier.doi | 10.3947/ic.2022.0048 | - |
| dc.relation.journalcode | J01053 | - |
| dc.identifier.eissn | 2092-6448 | - |
| dc.identifier.pmid | 35920266 | - |
| dc.subject.keyword | HIV | - |
| dc.subject.keyword | Korea | - |
| dc.subject.keyword | Cardiovascular diseases | - |
| dc.subject.keyword | Coronary disease | - |
| dc.contributor.alternativeName | Choi, Jun Yong | - |
| dc.contributor.affiliatedAuthor | Choi, Jun Yong | - |
| dc.identifier.scopusid | 2-s2.0-85137414341 | - |
| dc.identifier.wosid | 000875636600002 | - |
| dc.citation.volume | 54 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 409 | - |
| dc.citation.endPage | 418 | - |
| dc.identifier.bibliographicCitation | Infection and Chemotherapy, Vol.54(3) : 409-418, 2022-09 | - |
| dc.identifier.rimsid | 77702 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | HIV | - |
| dc.subject.keywordAuthor | Korea | - |
| dc.subject.keywordAuthor | Cardiovascular diseases | - |
| dc.subject.keywordAuthor | Coronary disease | - |
| dc.subject.keywordPlus | ANTIRETROVIRAL THERAPY | - |
| dc.subject.keywordPlus | VIRAL REPLICATION | - |
| dc.subject.keywordPlus | DISEASE | - |
| dc.subject.keywordPlus | FRAMINGHAM | - |
| dc.subject.keywordPlus | INTERRUPTION | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002884781 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
| dc.relation.journalResearchArea | Infectious Diseases | - |
| dc.identifier.articleno | e48 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.